Hypoxemia, Respiratory Distress Syndrome
Conditions
Keywords
Vibroacustic therapy, COVID19, Pneumonia
Brief summary
Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure
Detailed description
This study aims to recruit the required number of patients for statistical identification of the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance criteria will be presented by the duration of the course of respiratory failure and the duration of mechanical ventilation in the main and control groups. Optional performance criteria will be represented by oximetry values and standardization of laboratory parameters
Interventions
DEVICEVibroLUNG
Lungs intensive therapy
Sponsors
Astana Medical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Research involves single blinding (researcher statistician)
Intervention model description
Prospective\\retrospective study
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. adults 2. P/F less 300 torr 3. ARDS by Berlin convention 4. COVID 19 bilateral pneumonia
Exclusion criteria
1. children 2. acute brain stroke 3. acute coronary syndrome 4. pulmonary embolism 5. implanted pacemaker
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recovery respiratory fail | 5-7 days | Regression of respiratory failure under the influence of vibroacoustic therapy |
Countries
Kazakhstan
Contacts
Primary ContactIrina Mukatova, PhD
Outcome results
None listed